Skip to main content
$18.85 -$0.72 (-3.7%)

04:00 PM EST on 02/29/24

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)

CAPS Rating: No stars

Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada.

Current Price $18.85 Mkt Cap $1.3B
Open $19.80 P/E Ratio 26.74
Prev. Close $18.85 Div. (Yield) $0.00 (0.0%)
Daily Range $18.63 - $19.95 Volume 1,861,421
52-Wk Range $11.82 - $38.32 Avg. Daily Vol. 1,226,312

Caps

How do you think NASDAQ:AMLX will perform against the market?

Add Stock to CAPS Watchlist

All Players

3 Outperform
1 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AMLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:AMLX Summary

  • Sector:
  • Industry:
  • Tags:

Fools bullish on NASDAQ:AMLX are also bullish on:

Fools bearish on NASDAQ:AMLX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AMLX.

Recs

0
Member Avatar TMFang4apples (28.71) Submitted: 1/4/2024 8:19:18 AM : Outperform Start Price: $16.16 NASDAQ:AMLX Score: +8.64

With over $400 million in annualized sales of Relvyrio already and a $1.1 billion market cap this is a no brainier. The drug is already fully approved so failure in the Phoenix trial won't affect accessibility. It's sad, but the lack of availiable options will most likely lead to Sarepta-esque sales for years even if Phoenix is a flop.

Recs

0
Member Avatar TMFjimhalley (< 20) Submitted: 9/8/2022 7:01:13 PM : Underperform Start Price: $27.40 NASDAQ:AMLX Score: +57.36

Expectations for its ALS drug have sent the stock soaring, but the company has a long way to go to be profitable.

Leaderboard

Find the members with the highest scoring picks in AMLX.

Score Leader

TMFjimhalley

TMFjimhalley (< 20) Score: +57.36

The Score Leader is the player with the highest score across all their picks in AMLX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFjimhalley < 20 9/9/2022 Underperform 3W $27.40 -31.20% +26.16% +57.36 1 Comment
ababrmon 27.66 11/16/2023 Outperform 5Y $12.41 +51.87% +12.80% +39.07 0 Comment
TMFang4apples 28.71 1/4/2024 Outperform 5Y $16.16 +16.65% +8.00% +8.64 1 Comment
TMFGBudwell < 20 5/15/2023 Outperform 5Y $28.13 -32.99% +23.25% -56.24 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AMLX.